建业股份：10月24日召开董事会会议

Group 1 - The core point of the article is that Jianye Co., Ltd. held its 14th meeting of the 5th Board of Directors on October 24, 2025, to review the proposal regarding the company's Q3 2025 report [1] - For the year 2024, Jianye Co., Ltd.'s revenue composition is 95.88% from the chemical industry and 4.12% from other businesses [1] - As of the report date, Jianye Co., Ltd. has a market capitalization of 4.1 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - It highlights a conversation with Lu Gang, a partner at Chuangdong Investment, discussing the hot secondary market in biomedicine while the primary market faces fundraising challenges [1]